Sigilon Therapeutics, Inc. Pre-Tax Profit Margin 2021-2023 | SGTX
Sigilon Therapeutics, Inc. pre-tax profit margin from 2021 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-06-30 | $0.02B | $-0.03B | -172.22% |
| 2023-03-31 | $0.02B | $-0.04B | -246.67% |
| 2022-12-31 | $0.01B | $-0.04B | -338.46% |
| 2022-09-30 | $0.01B | $-0.06B | -458.33% |
| 2022-06-30 | $0.01B | $-0.07B | -660.00% |
| 2022-03-31 | $0.01B | $-0.07B | -720.00% |
| 2021-12-31 | $0.01B | $-0.08B | -770.00% |
| 2021-09-30 | $0.01B | $-0.07B | -616.67% |
| 2021-06-30 | $0.01B | $-0.07B | -478.57% |
| 2021-03-31 | $0.01B | $-0.06B | -461.54% |
| 2020-12-31 | $0.01B | $-0.05B | -415.38% |
